Cancer and its treatment can predispose patients to infections. My foremost clinical interest is taking care of patients who are experiencing infectious complications either from their underlying disease or in relation to their cancer chemotherapy.
My clinical practice directly influences my research in infection prevention and hospital epidemiology. As the Associate Director for Infection Control at Memorial Hospital, I am focused on advancing the prevention of healthcare-associated infections through the application of new technologies. In collaboration with the Infection Control Program and the Microbiology Laboratory, I work to develop new techniques to refine our molecular typing platform for more accurate and thorough surveillance and outbreak investigation. For more information on our grant-funded and institutionally supported research in infection prevention and hospital epidemiology, please see the Infection Control website.
- Clinical Expertise: Infectious Diseases
- Languages Spoken: English
- Education: MD, New York Medical College
- Residencies: St. Vincent's Hospital (New York); Danbury Hospital
- Fellowships: Stanford University Medical Center
- Board Certifications: Infectious Disease; Internal Medicine
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more